Search Results - "C. R. Benedict"

Refine Results
  1. 1

    A Simple Strategy for Crystal Engineering Water Clusters by Sansam, Benedict C. R, Anderson, Kirsty M, Steed, Jonathan W

    Published in Crystal growth & design (01-12-2007)
    “…We report the X-ray crystal structure of the protonated phenazine-2,3-diamine cation (3) salt (3)2SeO4·6H2O (4), which contains a discrete water decamer. This…”
    Get full text
    Journal Article
  2. 2

    Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism by MERTEN, M, PAKALA, R, THIAGARAJAN, P, BENEDICT, C. R

    Published in Circulation (New York, N.Y.) (18-05-1999)
    “…Platelets, on activation, release vesicular particles called platelet microparticles. Despite their procoagulant activity, their functional role in…”
    Get full text
    Journal Article
  3. 3

    Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels by Kuryshev, Y A, Brown, A M, Wang, L, Benedict, C R, Rampe, D

    “…Administration of the 5-hydroxytryptamine 3 receptor class of antiemetic agents has been associated with prolongation in the QRS, JT, and QT intervals of the…”
    Get more information
    Journal Article
  4. 4

    Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model by THIAGARAJAN, P, BENEDICT, C. R

    Published in Circulation (New York, N.Y.) (07-10-1997)
    “…The procoagulant effect of anionic phospholipid may play a major role in the development of arterial thrombosis. Annexin V, a calcium-dependent…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis by WEINBERG, E. O, SCHOEN, F. J, GEORGE, D, KAGAYA, Y, DOUGLAS, P. S, LITWIN, S. E, SCHUNKERT, H, BENEDICT, C. R, LORELL, B. H

    Published in Circulation (New York, N.Y.) (01-09-1994)
    “…We tested the hypotheses that long-term administration of the angiotensin-converting enzyme (ACE) inhibitor fosinopril will regress hypertrophy, modify the…”
    Get full text
    Journal Article
  7. 7

    New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA by BENEDICT, C. R, REFINO, C. J, KEYT, B. A, PAKALA, R, PAONI, N. F, THOMAS, G. R, BENNETT, W. F

    Published in Circulation (New York, N.Y.) (15-11-1995)
    “…The thrombolytic properties of a new variant of tissue plasminogen activator (TPA) (T103N, N117Q, KHRR 296-299 AAAA, or TNK-TPA) with longer plasma half-life,…”
    Get full text
    Journal Article
  8. 8

    The Cyclization of Farnesyl Diphosphate and Nerolidyl Diphosphate by a Purified Recombinant δ-Cadinene Synthase by Chauncey R. Benedict, Jia-Ling Lu, Pettigrew, Donald W., Jinggao Liu, Stipanovic, Robert D., Williams, Howard J.

    Published in Plant physiology (Bethesda) (01-04-2001)
    “…The first step in the conversion of the isoprenoid intermediate, farnesyl diphosphate (FDP), to sesquiterpene phytoalexins in cotton (Gossypium barbadense)…”
    Get full text
    Journal Article
  9. 9

    Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation by KOBA, S, PAKALA, R, WATANABE, T, KATAGIRI, T, BENEDICT, C. R

    “…Low density lipoprotein (LDL) and mildly oxidized low density lipoprotein (mox-LDL) are known mitogens for vascular smooth muscle cell (VSMC). Since…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Safe and effective management of hypertension with fixed-dose combination therapy: focus on losartan plus hydrochlorothiazide by Benedict, C R

    “…Treatment of hypertensive patients with fixed-dose combination therapy consisting of losartan and hydrochlorothiazide (HCTZ) has several potential benefits…”
    Get more information
    Journal Article
  12. 12

    Thromboxane A2 fails to induce proliferation of smooth muscle cells enriched with eicosapentaenoic acid and docosahexaenoic acid by PAKALA, Rajbabu, PAKALA, Rajashree, BENEDICT, C. R

    “…Thromboxane A2 (TXA2) released from aggregating platelets and injured vessel wall stimulates smooth muscle cell proliferation, which may contribute to the…”
    Get full text
    Journal Article
  13. 13

    Dominance of Charge-Assisted Hydrogen Bonding on Short Contacts and Structures that Crystallize with Z′ > 1 by Anderson, Kirsty M, Goeta, Andrés E, Martin, Jessica E, Mason, Sax A, McIntyre, Garry J, Sansam, Benedict C. R, Wilkinson, Clive, Steed, Jonathan W

    Published in Crystal growth & design (02-11-2011)
    “…An enantiotropic pair of polymorphs of (H2-o-PDA2+)4(H5O2 +)(SO4 2–)4(HSO4 –)·2H2O (1) interconvert at 140–142 K with a concomitant change in Z′. The details…”
    Get full text
    Journal Article
  14. 14

    Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology by VAN DEN BERG, E. G, SCHMITZ, J. M, BENEDICT, C. R, MALLOY, C. R, WILLERSON, J. T, DEHMER, G. J

    Published in Circulation (New York, N.Y.) (1989)
    “…Serotonin is released by activated platelets and may act as a mediator to initiate or sustain certain unstable syndromes of ischemic heart disease in humans…”
    Get full text
    Journal Article
  15. 15

    Single-Blind Study of the Effects of Intravenous Dolasetron Mesylate Versus Ondansetron on Electrocardiographic Parameters in Normal Volunteers by Benedict, Claude R, Arbogast, Robert, Martin, Lorene, Patton, Lavonne, Morrill, Bruce, Hahne, William

    Published in Journal of cardiovascular pharmacology (01-07-1996)
    “…SUMMARYA single-blind, randomized, five-way crossover, safety and tolerability trial was conducted to determine whether intravenous (i.v.) dolasetron mesylate…”
    Get full text
    Journal Article
  16. 16

    Local Effect of Serotonin Released during Coronary Angioplasty by Golino, Paolo, Piscione, Federico, Benedict, Claude R, Anderson, H. Vernon, Cappelli-Bigazzi, Maurizio, Indolfi, Ciro, Condorelli, Mario, Chiariello, Massimo, Willerson, James T

    Published in The New England journal of medicine (24-02-1994)
    “…Recent experimental and clinical observations indicate that intracoronary platelet activation at sites of endothelial injury and coronary-artery stenosis may…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids by Pakala, Rajashree, Pakala, Rajbaeu, Radcliffe, J.D., Benedict, C.R.

    “…Serotonin (5HT) released from aggregating platelets at sites of vascular injury is a known mitogen for vascular endothelial cells. Recent studies have…”
    Get full text
    Journal Article
  19. 19

    Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries by ASHTON, J. H, BENEDICT, C. R, FITZGERALD, C, RAHEJA, S, TAYLOR, A, CAMPBELL, W. B, MAXIMILIAN BUJA, L, WILLERSON, J. T

    Published in Circulation (New York, N.Y.) (01-03-1986)
    “…The data obtained in this study demonstrate that the concentration of serotonin is markedly elevated (18- to 27-fold) at the site of a coronary arterial…”
    Get full text
    Journal Article
  20. 20

    Differential induction of 3-hydroxy-3-methylglutaryl CoA reductase in two cotton species following inoculation with Verticillium by JOOST, O, BIANCHINI, G, BELL, A. A, BENEDICT, C. R, MAGILL, C. W

    Published in Molecular plant-microbe interactions (01-11-1995)
    “…Gossypium barbadense cottons are typically more resistant to wilt pathogens than are Gossypium hirsutum cultivars. Both species make terpenoid phytoalexins in…”
    Get full text
    Journal Article